• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病细胞特征在年轻和老年患者之间的差异:老年患者的细胞在体外过度生长,尽管HLA - DR抗原水平高,但抗原性低。

Difference between young and old patients in characteristics of leukemic cells: older patients have cells growing excessively in vitro, with low antigenicity despite high HLA-DR antigens.

作者信息

Giannoulis N, Ogier C, Hast R, Lindblom B, Sjögren A M, Reizenstein P

出版信息

Am J Hematol. 1984 Feb;16(2):113-21. doi: 10.1002/ajh.2830160203.

DOI:10.1002/ajh.2830160203
PMID:6230005
Abstract

Fifty-six patients with acute, non-lymphatic leukemia in the initial phase were studied. The poor prognostic signs were excessive in vitro growth, many HLA-DR-positive cells, or a low ratio of leukemic cell antigenicity to HLA-DR positivity and age. The cells from older patients formed more clusters (P less than 0.05), and they had less capacity to stimulate normal allogeneic lymphocytes (P less than 0.05) than those from younger patients. Cells forming many clusters also were more often (P less than 0.01) HLA-DR-positive than those forming few clusters. It is suggested that the prognosis in old patients with acute leukemia is poor in part because their leukemic cells have characteristics different from those of young patients.

摘要

对56例处于初始阶段的急性非淋巴细胞白血病患者进行了研究。预后不良的体征包括体外生长过度、许多HLA - DR阳性细胞,或白血病细胞抗原性与HLA - DR阳性率及年龄的比值较低。老年患者的细胞形成的集落更多(P < 0.05),并且与年轻患者的细胞相比,它们刺激正常异基因淋巴细胞的能力更低(P < 0.05)。形成许多集落的细胞HLA - DR阳性的频率也比形成集落少的细胞更高(P < 0.01)。提示老年急性白血病患者预后不良部分是因为其白血病细胞具有与年轻患者不同的特征。

相似文献

1
Difference between young and old patients in characteristics of leukemic cells: older patients have cells growing excessively in vitro, with low antigenicity despite high HLA-DR antigens.白血病细胞特征在年轻和老年患者之间的差异:老年患者的细胞在体外过度生长,尽管HLA - DR抗原水平高,但抗原性低。
Am J Hematol. 1984 Feb;16(2):113-21. doi: 10.1002/ajh.2830160203.
2
An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.一种能刺激混合淋巴细胞培养(MLC)和细胞介导的细胞毒作用(CMC)反应的HLA - DR阴性急性白血病。
Cancer Immunol Immunother. 1983;16(2):117-22. doi: 10.1007/BF00199243.
3
Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.患者白血病细胞上缺乏 II 类相关不变链肽可促进自身白血病反应性 CD4+ T 细胞的激活。
Cancer Res. 2011 Apr 1;71(7):2507-17. doi: 10.1158/0008-5472.CAN-10-3689. Epub 2011 Feb 10.
4
Antigens present on human myeloid leukemia cell lines.人类髓系白血病细胞系上存在的抗原。
Leuk Res. 1980;4(1):69-77. doi: 10.1016/0145-2126(80)90047-8.
5
Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.正常及慢性髓性白血病粒细胞/单核细胞祖细胞HLA-II类(DR、DQ)决定簇的表达
Cancer Res. 1986 Apr;46(4 Pt 1):1783-7.
6
Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.混合淋巴细胞-肿瘤细胞培养物中自然杀伤样活性的产生。I. HLA-DR抗原作为刺激分子的作用。
Nat Immun Cell Growth Regul. 1985;4(2):90-102.
7
Variability of the alloreactive T-cell response to human leukemic blasts.同种异体反应性T细胞对人白血病母细胞反应的变异性。
Leukemia. 1994 Apr;8(4):642-7.
8
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.单克隆抗体H25、H366和MY9与急性髓细胞白血病患者正常祖细胞和原始细胞的个体及联合反应性分析。
Leukemia. 1989 Jun;3(6):446-52.
9
Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.II类分子相关恒定链肽在髓系白血病母细胞上的表达预示着不良的临床预后。
Cancer Res. 2004 Aug 15;64(16):5546-50. doi: 10.1158/0008-5472.CAN-04-1350.
10
Plaque-forming cells in man. III. Generation of plaque-forming cells in allogeneic in vitro cultures of HLA-D/DR-incompatible B and T lymphocytes.人类中的噬斑形成细胞。III. HLA-D/DR不相容的B淋巴细胞和T淋巴细胞异体体外培养中噬斑形成细胞的产生
Scand J Immunol. 1984 May;19(5):419-24. doi: 10.1111/j.1365-3083.1984.tb00950.x.

引用本文的文献

1
Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.伊达比星:对其在成年急性髓系白血病患者中应用的药物经济学评价
Pharmacoeconomics. 1993 Oct;4(4):287-307. doi: 10.2165/00019053-199304040-00007.
2
Remission with high erythrocyte sedimentation rates in acute myeloid leukemia is of short duration.急性髓系白血病中红细胞沉降率高时的缓解期较短。
Blut. 1985 Oct;51(4):299-300. doi: 10.1007/BF00320526.
3
Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.
急性非淋巴细胞白血病细胞刺激同种异体T淋巴细胞的条件
Cancer Immunol Immunother. 1987;25(3):250-6. doi: 10.1007/BF00199155.
4
Age and the biology of acute myeloid leukemia.年龄与急性髓系白血病生物学
Ann Hematol. 1992 Mar;64(3):157-9. doi: 10.1007/BF01697405.